LH
insider transactionsLABCORP HOLDINGS INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-9.1K
0 buy · 9.1K sell
Net value · 90d
-$2.4M
$0 in · $2.4M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
4
0 buy · 9.1K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
EVP, Chief Legal Officer · 10b5-1
$201.1K
762 sh · $263.89
Own -17%
-
Sell·S
Adam H Schechter KEY
President & CEO · 10b5-1
$1.5M
5.9K sh · $254.50
Own -5%
-
Sell·S
SVP, Chief Accounting Officer · 10b5-1
$436.1K
1.6K sh · $267.05
Own -47%
-
Sell·S
EVP, Operations · 10b5-1
$224.1K
839 sh · $267.05
Own -19%
-
Other·F
Adam H Schechter KEY
President & CEO
$7.0M
26.1K sh · $268.38
Own -19%
-
Grant·A
Adam H Schechter KEY
President & CEO
$0
58.5K sh
Own +72%
-
Other·F
EVP, Pres Diagnostics & COO
$394.0K
1.5K sh · $268.38
Own -10%
-
Grant·A
EVP, Pres Diagnostics & COO
$0
3.0K sh
Own +27%
-
Other·F
EVP, Pres Diagnostics & COO
$1.2M
4.6K sh · $268.38
Own -29%
-
Grant·A
EVP, Pres Diagnostics & COO
$0
9.3K sh
Own +144%
-
Other·F
SVP, Chief Accounting Officer · 10b5-1
$202.6K
755 sh · $268.38
Own -18%
-
Grant·A
SVP, Chief Accounting Officer · 10b5-1
$0
2.4K sh
Own +129%
-
Other·F
EVP, Diagnostics
$121.0K
451 sh · $268.38
Own -6%
-
Grant·A
EVP, Diagnostics
$0
1.6K sh
Own +28%
-
Other·F
EVP, Corporate Affairs
$730.5K
2.7K sh · $268.38
Own -30%
-
Grant·A
EVP, Corporate Affairs
$0
6.4K sh
Own +247%
-
Other·F
EVP, Chief Marketing Officer
$492.7K
1.8K sh · $268.38
Own -19%
-
Grant·A
EVP, Chief Marketing Officer
$0
4.0K sh
Own +70%
-
Other·F
EVP, CIO & CTO
$102.5K
382 sh · $268.38
Own -7%
-
Grant·A
EVP, CIO & CTO
$0
1.3K sh
Own +33%
-
Other·F
EVP, Operations · 10b5-1
$190.8K
711 sh · $268.38
Own -14%
-
Grant·A
EVP, Operations · 10b5-1
$0
2.4K sh
Own +86%
-
Other·F
EVP, Chief Legal Officer
$121.0K
451 sh · $268.38
Own -9%
-
Grant·A
EVP, Chief Legal Officer
$0
1.6K sh
Own +46%
-
Other·F
EVP, CHRO
$772.7K
2.9K sh · $268.38
Own -36%
-
Grant·A
EVP, CHRO
$0
6.6K sh
Own +452%
-
Other·F
EVP, Pres of ED, CMO & CSO
$231.6K
863 sh · $268.38
Own -2%
-
Grant·A
EVP, Pres of ED, CMO & CSO
$0
2.0K sh
Own +6%
-
Other·F
EVP, Pres of ED, CMO & CSO
$1.1M
4.0K sh · $268.38
Own -10%
-
Grant·A
EVP, Pres of ED, CMO & CSO
$0
9.3K sh
Own +31%
-
Other·F
EVP, Pres, Central Labs & Intl
$129.1K
481 sh · $268.38
Own -9%
-
Grant·A
EVP, Pres, Central Labs & Intl
$0
1.2K sh
Own +29%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Kathryn W Kyle 10b5-1 | Sell S | 762 | $201.1K |
| May 11, 2026 | Adam H Schechter KEY 10b5-1 | Sell S | 5.9K | $1.5M |
| Mar 27, 2026 | Peter J Wilkinson 10b5-1 | Sell S | 1.6K | $436.1K |
| Mar 27, 2026 | Jonathan C Meltzer 10b5-1 | Sell S | 839 | $224.1K |
| Mar 26, 2026 | Adam H Schechter KEY | Other F | 26.1K | $7.0M |
| Mar 26, 2026 | Adam H Schechter KEY | Grant A | 58.5K | $0 |
| Mar 26, 2026 | Mark S Schroeder | Other F | 1.5K | $394.0K |
| Mar 26, 2026 | Mark S Schroeder | Grant A | 3.0K | $0 |
| Mar 26, 2026 | Mark S Schroeder | Other F | 4.6K | $1.2M |
| Mar 26, 2026 | Mark S Schroeder | Grant A | 9.3K | $0 |
| Mar 26, 2026 | Peter J Wilkinson 10b5-1 | Other F | 755 | $202.6K |
| Mar 26, 2026 | Peter J Wilkinson 10b5-1 | Grant A | 2.4K | $0 |
| Mar 26, 2026 | Bryan T Vaughn | Other F | 451 | $121.0K |
| Mar 26, 2026 | Bryan T Vaughn | Grant A | 1.6K | $0 |
| Mar 26, 2026 | Sandra D Van Der Vaart | Other F | 2.7K | $730.5K |
| Mar 26, 2026 | Sandra D Van Der Vaart | Grant A | 6.4K | $0 |
| Mar 26, 2026 | Amy B. Summy | Other F | 1.8K | $492.7K |
| Mar 26, 2026 | Amy B. Summy | Grant A | 4.0K | $0 |
| Mar 26, 2026 | Akinbolade Oyegunwa | Other F | 382 | $102.5K |
| Mar 26, 2026 | Akinbolade Oyegunwa | Grant A | 1.3K | $0 |
| Mar 26, 2026 | Jonathan C Meltzer 10b5-1 | Other F | 711 | $190.8K |
| Mar 26, 2026 | Jonathan C Meltzer 10b5-1 | Grant A | 2.4K | $0 |
| Mar 26, 2026 | Kathryn W Kyle | Other F | 451 | $121.0K |
| Mar 26, 2026 | Kathryn W Kyle | Grant A | 1.6K | $0 |
| Mar 26, 2026 | Anita Z Graham | Other F | 2.9K | $772.7K |
| Mar 26, 2026 | Anita Z Graham | Grant A | 6.6K | $0 |
| Mar 26, 2026 | Brian J Caveney | Other F | 863 | $231.6K |
| Mar 26, 2026 | Brian J Caveney | Grant A | 2.0K | $0 |
| Mar 26, 2026 | Brian J Caveney | Other F | 4.0K | $1.1M |
| Mar 26, 2026 | Brian J Caveney | Grant A | 9.3K | $0 |
| Mar 26, 2026 | Megan D. Bailey | Other F | 481 | $129.1K |
| Mar 26, 2026 | Megan D. Bailey | Grant A | 1.2K | $0 |
About LH insider trading
This page tracks insider transactions for LABCORP HOLDINGS INC. (LH) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.